BlueRock Therapeutics Compagnie réclamée
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Lire la suite
my brief experience has been very positive. i have been genuinely welcomed and colleagues seem eager to help me learn in a way that communicates they are invested in my success
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
fearless, humble, committed, self aware, experienced
Quelles sont les meilleures choses à propos de votre équipe?
impressed at the level of ownership for company goals and patients.
Quelle est la meilleure partie de votre programme de rémunération?
unable to fully respond at this early juncture. overall seems balanced and competitive.
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
Genuine desire to weave together expertise and disciplines. Awareness and eagerness to evolve
Qu’est-ce qui vous rend le plus heureux au travail?
the potential of the science. the genuine opportunity to make and impact and contribute to the vision
Other Employee Reviews for BlueRock Therapeutics
×